← Leaderboards
Dimitrios Karamichos
University Of North Texas Hlth Sci Ctr
$9,689,481
Attributed
$13,884,620
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,884,620 · 12
By mechanism
R01$12,237,958 · 8
R21$1,646,662 · 4
Top collaborators
- Jian-Xing Ma10 shared
- Nawajes Mandal8 shared
- James D Zieske4 shared
- Kyle A Emmitte2 shared
- Melissa Petersen1 shared
Most similar at University Of North Texas Hlth Sci Ctr
Same institution · by research overlap
- Jian-Xing Ma$33,274,759
- Melissa Petersen$593,968
Others in their field
Top investigators on “Cornea”
- Raymond Kraker · Jaeb Center For Health Research, Inc.$47,584,981
- Ehud Isacoff · University Of California Berkeley$23,946,000
- Mary Ann Stepp · George Washington University$18,098,163
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Reza Dana · Schepens Eye Research Institute$17,808,908
- Eric Pearlman · Case Western Reserve University$16,337,424
Research focus
CorneaAffectIn VivoBlindnessKeratoplastyIn VitroPreventOperative Surgical ProceduresCellsKeratoconusVisionCorneal DiseasesSignal TransductionExtracellular MatrixCorneal ScarTissuesCorneal StromaFutureFibroblasts3-DimensionalStromal CellsCicatrixIn Vitro ModelPublic Health
Grant awards (43)
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$465,357
R01 · FY2025 · EY · contact PI
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary$393,545
R01 · FY2025 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$378,750
R01 · FY2025 · EY · contact PI
Discovery of synthetic flavonoids for the treatment of corneal injury$185,000
R21 · FY2025 · EY · contact PI
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$465,357
R01 · FY2024 · EY · contact PI
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary$393,545
R01 · FY2024 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$378,750
R01 · FY2024 · EY · contact PI
Discovery of synthetic flavonoids for the treatment of corneal injury$222,000
R21 · FY2024 · EY · contact PI
The role of extracellular vesicles in keratoconus pathogenesis$185,000
R21 · FY2024 · EY · contact PI
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$477,357
R01 · FY2023 · EY · contact PI
Sphingolipids and their Impact in Corneal Wound Healing$405,358
R01 · FY2023 · EY
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary$393,545
R01 · FY2023 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$390,750
R01 · FY2023 · EY · contact PI
Utility of PIP as a Novel Keratoconus Biomarker$370,000
R01 · FY2023 · EY · contact PI
The role of extracellular vesicles in keratoconus pathogenesis$222,000
R21 · FY2023 · EY · contact PI
Utility of PIP as a Novel Keratoconus Biomarker$48,025
R01 · FY2023 · EY · contact PI
Sphingolipids and their Impact in Corneal Wound Healing$393,197
R01 · FY2022 · EY
Utility of PIP as a Novel Keratoconus Biomarker$358,900
R01 · FY2022 · EY · contact PI
Utility of PIP as a Novel Keratoconus Biomarker | Supplement$48,025
R01 · FY2022 · EY · contact PI
Sphingolipids and their Impact in Corneal Wound Healing$392,549
R01 · FY2021 · EY
Utility of PIP as a Novel Keratoconus Biomarker$294,181
R01 · FY2021 · EY · contact PI
Dietary Supplement of n-3 PUFA to Control Corneal Inflammation$153,052
R01 · FY2021 · EY
Sphingolipids and their Impact in Corneal Wound Healing$61,505
R01 · FY2021 · EY
Sphingolipids and their Impact in Corneal Wound Healing$426,685
R01 · FY2020 · EY
Exploring the role of gonadotropins in Down syndrome$403,584
R21 · FY2020 · EY · contact PI
Sex Hormones and Keratoconus$365,000
R01 · FY2020 · EY · contact PI
Utility of PIP as a Novel Keratoconus Biomarker$301,750
R01 · FY2020 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$242,857
R01 · FY2020 · EY
A Novel Pathogenic Pathway for Diabetic Keratopathy$47,143
R01 · FY2020 · EY
Sex Hormones and Keratoconus$362,500
R01 · FY2019 · EY · contact PI
Utility of PIP as a Novel Keratoconus Biomarker$300,625
R01 · FY2019 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$290,000
R01 · FY2019 · EY · contact PI
Sex Hormones and Keratoconus$362,500
R01 · FY2018 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$290,000
R01 · FY2018 · EY · contact PI
Sphingolipid signaling in corneal wound healing and fibrosis$192,315
R21 · FY2016 · EY · contact PI
Documentation of Novel Keratoconus Markers: In Vitro and In Vivo$362,600
R01 · FY2015 · EY · contact PI
Sphingolipid signaling in corneal wound healing and fibrosis$236,763
R21 · FY2015 · EY · contact PI
Transplantation of a self-assembled corneal substitute$475,300
R01 · FY2014 · EY
Documentation of Novel Keratoconus Markers: In Vitro and In Vivo$362,600
R01 · FY2014 · EY · contact PI
Transplantation of a self-assembled corneal substitute$460,750
R01 · FY2013 · EY
Documentation of Novel Keratoconus Markers: In Vitro and In Vivo$370,000
R01 · FY2013 · EY · contact PI
Transplantation of a self-assembled corneal substitute$485,000
R01 · FY2012 · EY
Transplantation of a self-assembled corneal substitute$470,900
R01 · FY2011 · EY